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surgery: Modifying effect of preoperative renal function.
Background. Acute renal failure (ARF) requiring dialysis is
an independent risk factor of mortality after cardiac surgery;
the level of preoperative renal function influences the risk of
both postoperative ARF and mortality. The relationship be-
tween mild renal dysfunction and mortality, and the modifying
effect of baseline renal function on this association, is less clear.
Methods. We studied 31,677 patients undergoing cardiac
surgery between 1993 and 2002. We used a logistic regression
model to assess the relationship between postoperative renal
dysfunction and mortality, while adjusting for preoperative re-
nal function, postoperative ARF requiring dialysis, and other
risk factors.
Results. The overall postoperative mortality rate was 2.2%
(698/31,677). For the entire cohort, a clinically relevant increase
in the adjusted risk of mortality occurred beyond 30% de-
cline in postoperative GFR. The mortality rate was 5.9% (N,
292/4986) among patients who developed 30% or greater de-
cline in postoperative GFR not requiring dialysis versus 0.4%
(N, 106/26,136) among those with <30% decline (P < 0.001).
A significant interaction between preoperative GFR and per-
cent change in postoperative GFR (P < 0.001) indicated that at
equivalent degrees of renal dysfunction, the mortality risk was
greater at a lower preoperative GFR. ARF requiring dialysis
was strongly associated with mortality in the model (odds ratio
4.2; 95% CI 3.1–5.7).
Conclusion. Renal dysfunction not requiring dialysis is an
independent risk factor of mortality after cardiac surgery. A
better preoperative GFR attenuates the effect of postoperative
renal dysfunction on mortality; this interaction needs to be con-
sidered while defining a clinically relevant threshold of ARF.
Acute renal failure (ARF) is a serious complication
after cardiac surgery, with an associated mortality rate
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in excess of 50% [1–5]. The level of baseline renal func-
tion prior to cardiac surgery also influences the risk of
both postoperative ARF as well as postoperative mor-
tality [4–6]. ARF was perceived as an unfortunate com-
plication that is proxy to the severity of other medical
illnesses; however, it is now apparent that severe ARF
requiring dialysis after cardiac surgery is an indepen-
dent risk factor of death [7]. It is less clear, however, as
to whether milder degrees of postoperative renal dys-
function independently influence mortality after cardiac
surgery. Furthermore, the modifying effect of preopera-
tive renal function on the association between postop-
erative renal dysfunction and mortality remains to be
examined.
Integral to the association between ARF and mortal-
ity is the issue of defining clinically relevant threshold of
renal dysfunction. The frequency of ARF varies widely
depending upon its definition; when defined in its most
severe form as requiring dialysis, the incidence of ARF
after cardiac surgery is usually less than 5% [4, 5, 8–10].
This translates into a significant challenge while design-
ing clinical trials because it mandates the enrollment of
a large number of patients in order to demonstrate the
efficacy of an intervention. Arbitrary definitions of less
severe degrees of ARF have been used to circumvent
this issue, but they fall short of demonstrating a longitu-
dinal association with “hard” clinical end points such as
hospital mortality [11–13].
We aim to study the effect of renal dysfunction not re-
quiring dialysis on mortality, in patients undergoing car-
diac surgery; to study the interaction between baseline
renal function and postoperative decline in glomerular
filtration rate (GFR) for its influence on mortality, after
adjusting for other confounding risk factors; and to deter-
mine a threshold of clinically relevant renal dysfunction
based upon its independent association with mortality.
The data indicate that renal dysfunction not requiring
dialysis is an independent risk factor of mortality, and
that a better preoperative renal function attenuates the
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Table 1. Definitions of risk factors affecting mortality
Risk factor Definition
Age In years (per 10-year increase)
Weight kg
Gender Female vs. male
Race White (89.1%), black (4%), and other (6.9%)
Albumin Preoperative serum albumin g/dL
Preoperative GFR Calculated by four-variable MDRD equation mL/min/1.73m2
Diabetes mellitus Insulin requiring diabetes mellitus
COPD History of chronic obstructive pulmonary disease requiring medical treatment
Peripheral vascular disease Evidence of peripheral vascular disease by angiography or noninvasive testing, history of vascular surgery, or
symptomatic vascular occlusion
Cerebrovascular disease History of stroke, carotid artery surgery, or >40% stenosis of either carotid artery proven by ultrasound or
angiography
LVF <35% Left ventricular function as determined by echocardiography, left ventriculography, or MUGA scan during the
preoperative period
Left main disease Left main coronary artery disease with >70% occlusion
Congestive heart failure History of congestive heart failure including history of dyspnea on exertion, orthopnea, or paroxysmal
nocturnal dyspnea prior to open-heart surgery
IABP use Preoperative use of intra-aortic balloon pump
Year of surgery Calendar year of surgery, 1993 to 2002
Prior surgery Previous history of open-heart surgery
Emergency surgery Emergency surgery as indicated by “E” in the anesthesia record sheet as per the criteria of the American
Society of Anesthesiology
CPB time Cardiopulmonary bypass time (minutes)
Surgery type Coronary artery bypass grafting (CABG), valve surgery, combined CABG and valve procedures, other cardiac
surgeries including pericardectomy, septal defect repair, etc.
mortality risk associated with postoperative decline in
GFR.
METHODS
Patient population
We studied 33,217 patients who underwent open-
heart surgery at the Cleveland Clinic Foundation be-
tween April 1993 and December 2002, as recorded in the
database of the department of Cardiothoracic Anesthe-
siology. This on-going registry is approved by the Institu-
tional Review Board to record perioperative information
in cardiac surgery patients. There were 34,562 surgeries
performed; for the purpose of this analysis, only the first
surgical episode was considered. We excluded 1540 pa-
tients from the analysis, including those requiring preop-
erative dialysis, preoperative extra-corporeal membrane
oxygenation, preoperative tracheostomy or mechanical
ventilation, heart transplant recipients, patients undergo-
ing procedures for automated implantable cardioverter-
defibrillator, left ventricular assist devices, sternal work,
and those with missing data. One hundred and sixty-four
patients met more than one criterion for exclusion. The
demographic distribution for the remaining 31,677 pa-
tients included 69.5% males (N, 22,012) and 31.5% fe-
males (N, 9665). Racial categories, as recorded in the
database, included white (89.1%; N, 28,230), black (4%;
N, 1264), and others (6.9%; N, 2183).
Definitions
The primary outcome was all-cause hospital mortality
after cardiac surgery. Renal dysfunction was determined
by calculating a percent decline in estimated GFR dur-
ing the postoperative period relative to baseline, but not
requiring dialysis. The preoperative GFR was estimated
by using baseline serum creatinine, whereas the postop-
erative GFR was estimated based upon peak serum cre-
atinine during the immediate postoperative period. Both
the four-variable MDRD equation [abstract; Levey AS
et al, J Am Soc Nephrol 11:A0828, 2000; K/DOQI guide-
lines for chronic kidney disease] and the Cockroft and
Gault equation were used to estimate GFR [14].
The preoperative risk factors considered in the anal-
ysis for their association with mortality are shown in
Table 1. They include demographic factors such as age,
gender, race, weight, and clinical risk factors, includ-
ing preoperative GFR, serum albumin, diabetes mellitus,
chronic obstructive pulmonary disease requiring treat-
ment, peripheral vascular disease, cerebrovascular dis-
ease, congestive heart failure, left ventricular dysfunction
(ejection fraction <35%), greater than 70% occlusion of
left main coronary artery, preoperative use of intra aor-
tic balloon pump (IABP), emergency surgery, and the
year of surgery. The intraoperative risk factors included
cardiopulmonary bypass time and the type of open-heart
surgery, including coronary artery bypass graft (CABG)
surgery, valve surgery, combined CABG and valve pro-
cedures, and other cardiac surgeries, such as ventricular
aneurysm repair, septal defect repair, etc. We also con-
sidered significant postoperative complications that can
affect mortality, including cardiac morbidity, neurologic
morbidity, severe ARF requiring dialysis, and serious in-
fection, including sepsis syndrome and septic shock. A
detailed account of the variables in the database, the
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definitions of all of the risk factors, and the postopera-
tive complications has been reported earlier [5, 15]. The
rationale for the selection of the potential risk factors in
the present analysis was based upon literature review of
the risk factors of mortality in cardiac surgery, our initial
validation of the database, and clinical plausibility.
Analysis
We calculated the percent change in the postoperative
GFR relative to baseline by using both the Cockroft and
Gault equation and the four-variable MDRD equation.
We compared the two estimates of GFR on the ability
to predict mortality from percent change in GFR using
the DeLong method for comparing two dependent re-
ceiver operating characteristics (ROC) curves. The area
under the curves, a measure of predictive ability, was 0.9,
and was similar for both equations (data not shown); thus,
GFR estimated by the four-variable MDRD equation
was used for subsequent models.
Patients who died and patients who survived were com-
pared on categorical risk factors using the chi-square test,
and on continuous risk factors using Wilcoxon rank sum
test. Multivariable logistic regression analysis was used
to assess the relationship between postoperative decline
in GFR and mortality while adjusting for preoperative
GFR, postoperative ARF requiring dialysis, and other
risk factors. To assess whether preoperative renal func-
tion modified the relationship between renal dysfunction
and mortality, we included the interaction of preopera-
tive GFR and percent decline in postoperative GFR in
the model. The risk of mortality was expressed as odds ra-
tios and 95% confidence intervals (95% CI), in which the
reference group was patients with a preoperative GFR of
90 mL/min/1.73m2 without any decline in postoperative
period.
Statistical analyses were conducted using SAS 8.2 (SAS
Institute, Cary, NC, USA). All tests were two tailed and
performed at a significance level of 0.05.
RESULTS
Postoperative GFR and mortality rates
The overall mortality rate after cardiac surgery was
2.2% (698/31,677). Tables 2 and 3 show the distribution
of comorbid risk factors across patients who survived ver-
sus those who died after open-heart surgery. Patients who
died differed significantly from patients who survived on
all of the risk factors. Of note, the median preoperative
GFR was 72 mL/min/1.73m2 among those who survived,
whereas it was 57 mL/min/1.73m2 among those who died.
There were 555 patients who developed severe ARF re-
quiring dialysis, with an associated mortality rate of 54%;
for the remaining 31,122 patients, the overall mortality
rate was 1.3% (N, 398). Figure 1 shows the continuous re-
lationship between percent change in postoperative GFR
and the risk of mortality by logistic regression model
(adjusted for all of the comorbid risk factors and post-
operative complications, including dialysis requirement).
After considering the median preoperative GFR in the
study population, a clinically relevant increase in the risk
of mortality occurs beyond 30% decline in postoperative
GFR. There were 4986 patients who developed a 30% or
greater decline in postoperative GFR but did not require
dialysis; the mortality rate among this subgroup of pa-
tients was 5.9% (N, 292/4986), whereas it was 0.4% (N,
106/26,136) among patients with <30% decline in post-
operative GFR (P < 0.001).
Interaction of preoperative GFR and
postoperative renal dysfunction
We hypothesized that the clinically relevant threshold
of renal dysfunction for the overall sample, as determined
by the risk of death, will be modified by the level of pre-
operative GFR. In the mortality model, the interaction
of preoperative GFR and percent change in postopera-
tive GFR were statistically significant (P < 0.001), which
supported our hypothesis.
This interaction was examined by calculating odds ra-
tios for mortality at different levels of baseline renal
function, as per the categories of chronic kidney disease
suggested by the K/DOQI guidelines, versus a reference
group with a preoperative GFR of 90 mL/min/1.73m2 and
no decline in their postoperative GFR. Figure 2 shows
the odds ratios of mortality associated with postopera-
tive decline in GFR at different levels of baseline renal
function. It indicates a curvilinear relationship between
an incremental risk of mortality and postoperative de-
cline in GFR, which is altered by the level of baseline
renal function. As indicated in Table 4, the odds ratio of
mortality was higher with a lower level of preoperative
renal function, at equivalent degrees of decline in postop-
erative GFR. For instance, among patients with preoper-
ative baseline GFR of 90, 60, and 30 mL/min/1.73m2 and
a 30% reduction in postoperative GFR relative to base-
line, the odds ratios of mortality were 5.0 (CI, 4.0–6.1),
9.4 (CI, 6.6–13.3), and 17.7 (CI, 10.6–29.5), respectively.
We interpret these observations to indicate that a better
preoperative renal function offsets the risk of mortality
associated with postoperative renal dysfunction.
The distribution of morbidities across patients with
different degrees of postoperative renal dysfunction is
shown in Table 5. The frequency of all of the morbidi-
ties was higher among patients with worsening degrees
of renal dysfunction. The multivariate model, after ac-
counting for the interaction of preoperative GFR, also
adjusts for the effects of postoperative complications on
mortality, including ARF requiring dialysis. Table 6 shows
the odds ratios of mortality associated with postoperative
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Table 2. Univariate comparison of comorbid risk factors for mortality
Died Survived
Categorical risk factors N = 698 (2.2%) N = 30,979 (97.8%) P valuec
Gender <0.001
Male (N = 22,012) 389 (55.7%) 21,623 (69.8%)
Female (N = 9665) 309 (44.3%) 9356 (30.2)
Race 0.035
White (N = 28,230) 621 (89%) 27,609 (89.1%)
Black (1264) 39 (5.6%) 1225 (4%)
Other (2183) 38 (5.4%) 2145 (6.9%)
Diabetes mellitus <0.001
Insulin requiring (N = 2738) 93 (13.3%) 2645 (8.5%)
Non-insulin requiring (N = 5079) 123 (17.6%) 4956 (16%)
None (N = 23,860) 482 (69.1%) 23,378 (75.5%)
COPD <0.001
Yes (N = 2591) 122 (17.5%) 2469 (8%)
No (N = 29,086) 576 (82.5%) 28,510 (92%)
Peripheral vascular disease <0.001
Yes (N = 3805) 163 (23.4%) 3642 (11.8%)
No (N = 27,872) 535 (76.7%) 27,337 (88.2%)
Cerebrovascular disease <0.001
Yes (N = 5435) 205 (29.4%) 5230 (16.9%)
No (N = 26,242) 493 (70.6%) 25,749 (83.1%)
Left ventricular function <35% <0.001
Yes (N = 3541) 137 (19.6%) 3404 (11%)
No (N = 28,136) 561 (80.4%) 25,575 (89%)
Left main disease 0.001
Yes (N = 1634) 55 (7.9%) 1579 (5.1%)
No (N = 30,043) 643 (92.1) 29,400 (94.9%)
Congestive heart failure <0.001
Yes (N = 8465) 365 (52.3%) 8100 (26.2%)
No (N = 23,212) 333 (47.7%) 22,879 (73.9%)
IABPa use <0.001
Yes (N = 474) 55 (7.9%) 419 (1.4%)
No (N = 31,203) 643 (92.1%) 30,560 (98.7%)
Prior surgery <0.001
Yes (N = 6847) 257 (36.8%) 6590 (21.3%)
No (N = 24,830) 441 (63.2%) 24,389 (78.7%)
Emergency surgery <0.001
Yes (N = 941) 86 (12.3%) 855 (2.8%)
No (N = 30,736) 612 (87.7%) 30,124 (97.2%)
Surgery type <0.001
CABGb only (N = 16,646) 265 (38%) 16,381 (N = 52.9%)
Valve only (N = 8158) 154 (22.1%) 8004 (N = 25.8%)
Combined (N = 5122) 196 (28.1%) 4926 (N = 15.9%)
Other (N = 1751) 83 (11.9%) 1668 (N = 5.4%)
a Intra-aortic balloon pump.
b Coronary artery bypass grafting.
c Chi-square test.
Table 3. Univariate comparison of continuous variables for mortality
Died Survived
(N = 698) (N = 30,979)
Risk factors Median (q1, q3)a Median (q1, q3) P valueb
Age years 71.8 (64.2, 77.0) 65.3 (55.8, 72.6) <0.001
Weight kg 74.0 (64.0, 87.0) 80.0 (70.0, 91.0) <0.001
Albumin g/dL 3.8 (3.3, 4.2) 4.2 (3.8, 4.4) <0.001
Preoperative GFR mL/min/1.73m2 57.0 (41.6, 74.9) 72 (57.9, 87.9) <0.001
CPB∗∗ time minutes 134.5 (95.0, 186.0) 97.0 (71.0, 126.0) <0.001
CPB, cardiopulmonary bypass; GFR, glomerular filtration rate.
aq1, first quartile/25th percentile; q3, third quartile/75th percentile.
bWilcoxon rank-sum test.
morbidities. Expectedly, ARF requiring dialysis in-
creased the risk of mortality with an odds ratio of 4.2
(95% CI, 3.1–5.7). The other postoperative complica-
tions that were independent determinants of mortality
included cardiovascular morbidity (odds ratio 8.3; 95%
CI, 6.2–10.9), neurologic morbidity (odds ratio 6.1; 95%
CI, 4.6–8.1), and serious infection (odds ratio 3.3; odds
ratio, 2.6–4.2).
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Fig. 1. Continuous relationship between postoperative renal dysfunc-
tion and mortality risk. ∗Logistic regression model adjusted for all of
the risk factors in Table 1, as well as postoperative morbidities, includ-
ing serious infections, cardiovascular morbidity, neurologic morbidity,
and acute renal failure requiring dialysis.
DISCUSSION
Although many studies have examined the effect of
preoperative comorbid risk factors on mortality after
cardiac surgery [6, 16–21], relatively few have studied
the independent influence of ARF on mortality [7, 22].
The present study demonstrates that even less severe de-
grees of renal dysfunction adversely influences patient
survival after cardiac surgery. It extends this information
by studying the interrelationship between preoperative
GFR, postoperative renal dysfunction, and mortality in-
dependent of other major risk factors. The study also
confirms the association between severe ARF requiring
dialysis and mortality after cardiac surgery.
The qualitative effects of dialysis requiring ARF on
mortality after cardiac surgery have been reported [7]. In
a multicenter observational study from the Veterans Af-
fairs health system, Chertow et al analyzed a large cohort
that included 42,773 patients, <1% of which were women.
After adjusting for the preoperative risk factors as well as
other postoperative morbidities that may influence mor-
tality, the odds ratio of mortality associated with ARF
requiring dialysis was 7.9. Although this study pointed
out an important association between severe ARF and
mortality, it did not assess the effects of relatively subtle
degrees of renal dysfunction. Moreover, the cohort was
not well represented by differences in gender, which is es-
pecially important because female gender has been well
recognized as an independent risk factor of morbidity and
mortality after cardiac surgery [23–25].
The present study demonstrates a link between non-
dialysis requiring renal dysfunction and an increased risk
of mortality after cardiac surgery. This effect was inde-
pendent of other major risk factors, including severe ARF
requiring dialysis. Furthermore, the cohort was well rep-
resented by differences in gender (31.5% females) and
race, which were accounted for as risk factors in the lo-
gistic regression model.
There are few studies that have examined the effects
of less severe renal dysfunction on mortality. Levy et al
were among the first investigators to address this ques-
tion in the setting of nephrotoxic renal failure secondary
to the administration of radio contrast agents [26]. They
performed a retrospective case-control analysis to exam-
ine the effect of ARF on mortality independent of other
comorbidities. In this single-center study, ARF was arbi-
trarily defined as a 25% or greater increase in serum crea-
tinine at 2 days after the administration of contrast. There
were 174 matched pairs of ARF patients. The overall mor-
tality in patients with ARF was 34% compared to 7%
among the matched control patients who did not develop
ARF. The adjusted odds ratio of mortality associated with
ARF was 5.5. This information regarding the relationship
between the magnitude of serum creatinine elevation and
mortality has been widely used to define ARF by subse-
quent clinical trials in the setting of nephrotoxic renal
injury [11–13, 27]. It should be noted, however, that 12%
of the subjects with ARF, as defined in this study, subse-
quently went on to require renal replacement therapy; the
mortality rate in this subgroup was 62%. Thus, the effects
of less severe degrees of renal dysfunction on mortality
may have been confounded by the subgroup that subse-
quently developed severe ARF requiring dialysis. More-
over, using an arbitrary definition of renal dysfunction ad
hoc in order to study its association with mortality can
introduce an ascertainment bias. In a more recent study,
Lassnigg et al [22] examined a cohort of 4118 patients un-
dergoing cardiothoracic surgery. This analysis examined
the effects of increments of 0.1 mg/dL in serum creatinine
at 48 hours after surgery on mortality. The multivariate
analysis adjusted for other preoperative risk factors and
postoperative dialysis requirement. However, the rela-
tion between change in creatinine and mortality did not
account for serious postoperative complications, such as
infections, sepsis, cardiac complications, etc., which are
known to be major contributors to postoperative mor-
tality independent of ARF [5, 7, 28, 29]. Both of these
studies fell short of examining the modifying influence of
baseline renal function on a clinically relevant threshold
of renal dysfunction.
The present analysis describes the relationship be-
tween renal dysfunction and mortality among cardiac
surgery patients. We assessed the continuous relationship
between renal dysfunction not requiring dialysis and mor-
tality after adjusting for other potential risk factors. We
did so by accounting for the major preoperative and in-
traoperative comorbid risk factors as well serious postop-
erative morbidities. Thus, effects of less severe degrees of
renal dysfunction on mortality were not only independent
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Fig. 2. Modifying effect of various levels of baseline renal function on the threshold of postoperative renal dysfunction. ∗Logistic regression model
adjusted for all other variables in Table 1 and all of the postoperative morbidities listed in Table 5. GFR, glomerular filtration rate.
Table 4. Modifying effect of preoperative GFR on the risk of mortality associated with postoperative renal dysfunctiona
Odds ratio (95% CI) for mortalityc
Baseline GFRb 10% drop in GFR 30% drop in GFR 50% drop in GFR
90 mL/min/1.73 m2 1.7 (1.6–1.8) 5.0 (4.0–6.1) 14.4 (10.2–20.4)
60 mL/min/1.73 m2 4.1 (3.1–5.6) 9.4 (6.6–13.3) 21.2 (14.0–32.1)
30 mL/min/1.73 m2 10.1 (5.9–17.2) 17.7 (10.6–29.5) 31.1 (18.6–52.0)
aLogistic regression model adjusted for all of the other risk factors in Table 1 and postoperative morbidities listed in Table 3.
bGlomerular filtration rate estimated by the four-variable MDRD equation.
cOdds ratios of mortality calculated with reference to a baseline GFR of 90 mL/min/1.73m2 without any decline in postoperative GFR.
of the influence of dialysis requiring ARF, but also ad-
justed for other major determinants of mortality.
Baseline renal function before cardiac surgery is an
independent risk factor of both postoperative ARF as
well as postoperative mortality. We hypothesized that
a threshold of clinically relevant renal dysfunction in a
given cohort will be modified by the level of preopera-
tive baseline renal function. To test the hypothesis sta-
tistically, we examined a model of interaction between
preoperative GFR and postoperative renal dysfunction
for its independent effect on mortality. Expectedly, at
equivalent degrees of postoperative renal dysfunction,
the risk of mortality was higher at a lower level of preop-
erative GFR. Said in another way, the risk of mortality
after cardiac surgery associated with renal dysfunction is
offset by a better preoperative renal function. It should
be noted, however, that the median preoperative GFR
in our cohort was 72 mL/min/1.73m2, and that the num-
ber of patients with severe impairment of baseline renal
function was relatively small.
Although there is an unequivocal association be-
tween severe ARF and mortality, the event rate of ARF
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Table 5. Distribution of morbidities across patients with different degrees of renal dysfunction
ARFa requiring 30% or greater decline in <30% decline in
dialysis GFRb (no dialysis) GFRb (no dialysis)
Morbidities N = 555 (%) N = 4986 (%) N = 26,136 (%) P valuec
Cardiac morbidity <0.001
Yes 169 (30.5) 253 (5.1) 174 (0.67)
No 386 (69.5) 4733 (94.9) 25,962 (99.3)
Neurologic morbidity <0.001
Yes 85 (15.3) 272 (5.5) 313 (1.2)
No 470 (84.7) 4714 (94.5) 25,823 (98.8)
Serious infection <0.001
Yes 322 (58) 518 (10.4) 222 (0.85)
No 233 (42) 4468 (89.6) 25,914 (99.2)
aAcute renal failure.
bGlomerular filtration rate.
cChi-square test for all pairwise comparisons.
requiring dialysis is very low, with a frequency of less than
5%. This limits the ability of clinical trials pertaining to
the prevention or treatment of ARF to demonstrate clear
benefits by necessitating the enrollment of a large number
of patients. To circumvent this difficulty, several studies
have used arbitrary definitions of less severe degrees of
renal failure. Using the relatively “liberal” definition of
outcome optimizes the event rate, allowing us to enhance
the assessment of efficacy of therapy. It then becomes
pivotal, however, to demonstrate that whether relatively
subtle degree of renal dysfunction does indeed affect mor-
tality, independent of other comorbidities. In the present
study, instead of arbitrarily defining renal dysfunction, we
describe the interrelationship between decline in GFR
and mortality; the data indicate that a clinically relevant
threshold of renal dysfunction can be significantly altered
by the interaction of baseline renal function, even after
accounting for other major risk factors.
There are limitations to this analysis. The use of any
of the available equations to estimate GFR in the setting
of ARF has its own drawbacks. However, the purpose
of this analysis was not to accurately quantify the GFR,
but rather to attempt to objectively define postopera-
tive renal dysfunction based upon its ability to identify
a group of patients with an increased risk of mortality.
Another limitation of the study is that the database does
not record either the cause of death or the temporal as-
sociation between the postoperative complications on all
patients. Thus, the reasons why patients with mild renal
dysfunction are at an increased risk of death can only
be speculated. The data do indicate, however, that the
presence of complications, such as serious infection or
cardiac morbidity, which can be attributed as causes of
death, were more frequent among patients with worsen-
ing degree of renal dysfunction. Thus, even if a particular
morbidity was related partly to preceding renal dysfunc-
tion (e.g., serious infections), it would have been identi-
fied as an independent contributor to patient mortality by
the multivariate model. Consequently, we believe that the
influence of renal dysfunction on mortality may actually
Table 6. Adjusted odds ratiosa for mortality associated with
postoperative complications
Odds ratio (95%
Postoperative morbidity confidence interval) P value
Cardiac morbidity 8.3 (6.2–10.9) <0.001
Neurologic morbidity 6.1 (4.6–8.1) <0.001
Serious infection 3.3 (2.6–4.2) <0.001
ARF requiring dialysis 4.2 (3.1–5.7) <0.001
aOdds ratios adjusted for all of the preoperative comorbid variables in Table
1, including the interaction of preoperative renal function.
be a conservative estimate. There could be other factors
that may influence mortality, and were not recorded in
the database. But we have accounted for the majority
of clinically relevant variables that can affect mortality
after cardiac surgery, including the major postoperative
complications and the interaction of preoperative GFR.
CONCLUSION
Renal dysfunction not requiring dialysis is an indepen-
dent risk factor of mortality after cardiac surgery. A bet-
ter preoperative renal function attenuates the effect of
postoperative renal dysfunction on mortality, and that
this interaction needs to be considered while defining a
clinically relevant threshold of ARF. We interpret these
observations to indicate that prevention or treatment of
even subtle degrees of renal dysfunction may portend a
significant survival benefit.
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